Company:Â Iomai [1]
Starting stock price: $4.85
Ending stock price: $1.03
Percent Change: -78.76%
Details: Iomai reported in May that it's needle-free flu vaccine demonstrated less of an immune response than an injection, sending its stock down 35%. The company is also developing a patch for traveler's diarrhea that has delivered promising results, and is working on two immunostimulant patches for pandemic flu.
More News:
Iomai vax patch guards against traveler's diarrhea. Report [2]
Vaccine-maker Iomai files $83M IPO. Report [3]
Links:
[1] http://www.iomai.com/
[2] http://www.fiercebioresearcher.com/vaccines/story/iomai-vax-patch-guards-against-traveler-s-diarrhea/2008-02-14
[3] http://www.fiercebiotech.com/story/vaccine-maker-iomai-files-83m-ipo/2005-10-03
[4] http://www.fiercepharma.com/special-reports/interpharm-worst-pharma-stocks-2007
[5] http://www.fiercepharma.com/special-reports/worst-pharma-stocks-2007
[6] http://www.fiercepharma.com/special-reports/nastech-pharmaceuticals-worst-pharma-stocks-2007